Cancer incidence in Sirte area, middle region of Libya: first results from Sirte Oncology Centre
Keywords:
Cancer, Malignancy, Cancer Incidence, Registry, LibyaAbstract
Cancer is a major health problem particularly in developing countries with limited cancer data. Therefore, cancer-registry data and studying the incidence are necessary for a local epidemic. The aim of the current study was to estimate the incidence of cancers in Sirte area that has never been studied. Materials and Methods: A retrospective study of cancer cases diagnosed in the pathology department at Sirte Oncology Centre from January 2021 to December 2023.
Results: Out of 174 diagnosed cancer cases, 48.3% were males, and most of reported malignant cases (63.2%) were at age greater than forty. Breast cancer was the commonest cancer among all malignant cases (25.3%), and was the commonest cancer among the females (46.7%), while bladder cancer was the commonest cancer in males (34.5%). Cancers of both genders has been increased during the studied period in a similar pattern. Conclusion: Breast cancer and bladder cancer were the commonest cancers in females and males respectively. The incidence of cancers in Sirte city has increased with the years of study. Cancer registry and performing further cancer epidemiological studies focused on cancers is critical, particularly after the age of forty.
References
. Wild C, Weiderpass E, Stewart BW. World cancer report: cancer research for cancer prevention. International Agency for Research on Cancer; 2020.
Organization WH. Cancer. 2022;
Organization WH. Global cancer burden growing, amidst mounting need for services. 2024;
Silva I dos S, Cancer IA for R on. Cancer Epidemiology: Principles and Methods. IARC; 1999.
Leal YA, Fernández-Garrote LM, Mohar-Betancourt A, Meneses-García A. The importance of registries in cancer control. salud pública de méxico. 2016;58(2):309–316.
Leal YA. The Role of Registration in Cancer Control and Prevention. Cancer Bioinformatics. 2022;
International Agency on Research on Cancer (IARC). IARC Regional Hubs for Cancer Registration [cited 2024 October11].
BenNasir E, El Mistiri M, McGowan R, Katz RV. Oral cancer in Libya and development of regional oral cancer registries: A review. The Saudi Dental Journal. 2015;27(4):171–179.
El Mistiri M, Verdecchia A, Rashid I, et al. Cancer incidence in eastern Libya: The first report from the Benghazi Cancer Registry, 2003. Intl Journal of Cancer. 2007;120(2):392–397.
Elzouki I, Benyasaad T, Altrjoman F, et al. Cancer Incidence in Western Region of Libya: Report of the Year 2009 from Tripoli Pathology-based Cancer Registry. Libyan Journal of Medical Sciences. 2018;2(2):45.
El Mistiri M, Salati M, Marcheselli L, et al. Cancer incidence, mortality, and survival in Eastern Libya: updated report from the Benghazi Cancer Registry. Annals of Epidemiology. 2015;25(8):564–568.
Akhtar SS, Abu Bakr MA, Dawi SA, IKRAM-UL-HUQ. Cancer in Libya—a retrospective study. Afr J Med Med Sci. 1993;(22):17–24.
Ismail F, Elsayed AG, El-Garawani I, Abdelsameea E. Cancer incidence in the Tobruk area, eastern Libya: first results from Tobruk Medical Centre. Epidemiol Health. 2021;43:e2021050.
Gusbi E, Eltaib FI, Abrahem AF, et al. Cancer Incidence in Southern Libya: Updated Report from 2016 to 2018. Libyan Journal of Medical Sciences. 2021;5(1):11.
Beyased T, Altrjoman F, Enattah N, et al. Cancer Incidence in Western Libya: First Results from Tripoli Medical Center. Ibnosina Journal of Medicine and Biomedical Sciences. 2017;9:37–45.
Zarmouh A, Almalti A, Alzedam A, et al. Cancer incidence in the middle region of Libya: Data from the cancer epidemiology study in Misurata. Cancer Reports. 2022;5(1):e1448.
El Mistiri M, Pirani M, El Sahli N, et al. Cancer profile in Eastern Libya: incidence and mortality in the year 2004. Annals of Oncology. 2010;21(9):1924–1926.
El Mistiri M, Verdecchia A, Rashid I, et al. Cancer incidence in eastern Libya: The first report from the Benghazi Cancer Registry, 2003. Intl Journal of Cancer. 2007;120(2):392–397.
Bodalal Z, Azzuz R, Bendardaf R. Cancers in eastern Libya: First results from Benghazi medical center. World journal of gastroenterology: WJG. 2014;20(20):6293.
El Mistiri M, El-Mangush M, El-Sahli N, et al. Cancer incidence in Eastern Libya: preliminary result of the year 2003. La Tunisie médicale. 2006;83 Suppl 12:18–9.
Ibrahim AS, Khaled HM, Mikhail NN, Baraka H, Kamel H. Cancer incidence in egypt: results of the national population-based cancer registry program. J Cancer Epidemiol. 2014;2014:437971.
Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389(10074):1134–1150.
Saheb Sharif-Askari N, Bendardaf R, Saheb Sharif-Askari F, El Tabbal AM, El Ayan MA. Incidence of bladder cancer in Benghazi, Libya over the past three decades. Scientific Reports. 2018;8(1):10822.
Alhdiri MA, Samat NA, Mohamed Z. Risk Estimation for Lung Cancer in Libya: Analysis Based on Standardized Morbidity Ratio, Poisson-Gamma Model, BYM Model and Mixture Model. Asian Pacific Journal of Cancer Prevention : APJCP. 2017;18(3):673.
van der Willik KD, Rojas-Saunero LP, Labrecque JA, et al. Pathology-confirmed versus non pathology-confirmed cancer diagnoses: incidence, participant characteristics, and survival. Eur J Epidemiol. 2020;35(6):557–565.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
